I suppose most people don't realize the magnitude of this yet. Having independent support for its research goes well beyond the company touting its successes.
In my opinion, this is an indication that the company may finally have a path to revenue generating products - something that propels most bio companies to 100x's their market value. That kind of potential makes it not worth selling out at this point.
It surprises me there's not more traffic about it on this message board.
News 
Market Data 
Discover 
